| Literature DB >> 34991075 |
Natalie S Callander1, Muhamed Baljevic2, Kehinde Adekola3, Larry D Anderson4, Erica Campagnaro5, Jorge J Castillo6, Caitlin Costello7, Srinivas Devarakonda8, Noura Elsedawy9, Matthew Faiman10, Alfred Garfall11, Kelly Godby12, Jens Hillengass13, Leona Holmberg14, Myo Htut15, Carol Ann Huff16, Malin Hultcrantz17, Yubin Kang18, Sarah Larson19, Michaela Liedtke20, Thomas Martin21, James Omel22, Douglas Sborov23, Kenneth Shain24, Keith Stockerl-Goldstein25, Donna Weber26, Ryan A Berardi27, Rashmi Kumar27, Shaji K Kumar28.
Abstract
The NCCN Guidelines for Multiple Myeloma provide recommendations for diagnosis, initial workup, treatment, follow-up, and supportive care for patients with various plasma cell neoplasms, including multiple myeloma. These NCCN Guidelines Insights highlight some of the important updates/changes specific to the treatment of patients with multiple myeloma in the 2022 version of the guidelines.Entities:
Mesh：
Year: 2022 PMID： 34991075 DOI： 10.6004/jnccn.2022.0002
Source DB: PubMed Journal: J Natl Compr Canc Netw ISSN： 1540-1405 Impact factor: 11.908